A to Z List - Medication Information Jude Children's Research Hospital.- Disclaimer / Registrations / Copyright Statement - Privacy Policy - Notice of Privacy Practices - Linking Policy - Help A to Z List - Medication Information A to Z List - Medication Information abacavir, lamivudine, zidovudine, trizivir, acyclovir, allopurinol, amifostine, amitriptyline, amlodipine, amoxicillin, clavulanic_acid, augmentin,...
author: St. Jude Children's Research Hospital
Preview of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy - Thomson Scientific Thomson.com - - - - - Advanced Search - - - EN : JP : CN : KR -- - - Thomson Scientific : Meeting Previews : 2004 : Preview of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy PREVIEW OF THE 44TH INTERSCIENCE CONFERENCE ON ANTIMICROBIAL AGENTS AND CHEMOTHERAPY Date: 30 October - 2 November 2004 Location: Washington DC, USA Coverage The 44th Annual...
http://www.biosis.org/ts/media/cdjournals/gazettenews/2000/CPG_News_0018.pdf MAY 5TH 2000 WEEK 18 DRUG PATENTING IN CONTEXT Current Patents Gazette is the most rapid competitive intelligence service covering innovation in the pharmaceutical industry.
Gazette Highlights News 2000 - Thomson Scientific Thomson.com - - - - - Advanced Search - - - EN : JP : CN : KR -- - - Thomson Scientific : Gazette Weekly Highlights News : Gazette Highlights News 2000 - Gazette Highlights News 2000 Click on a week to view more Week 52: There may be clues this week to the identity of protein tyrosine KDR kinase inhibitors that Celltech has in preclinical evaluation for cancer.
BioPortfolio Limited New Developments and Major Issues in Antifungal Treatments 3.1 Fungal Drug Discovery 3.2 Future Antifungal Drugs 3.3 Current Systemic Treatments 3.4 High Clinical Unmet Needs In the Antifungal Market 3.5 Research Direction and Increasing Resistance Rates 3.6 The Main Areas and Drug Targets of Antifungal Research 3.7 Fungal Virulence and Drug Targeting 3.8 Fungal Genome Sequencing...
BioPortfolio Limited Antifungals - More Data, More Prescriptions TABLE OF CONTENTS CHAPTER 1 EXECUTIVE SUMMARY 3 Scope of the analysis 3 Datamonitor insight into the antifungal market 4 The systemic antifungal market has experienced strong growth since 1999, increasing in value from $2.1 billion to $3.3 billion in 2003, representing a CAGR of 11.4%.
BioPortfolio Limited Antifungals: 2004 and Beyond Table of Contents Executive Summary 4 Topics considered in this report 6 Companies mentioned in this report 6 Methodology 7 Information Sources 7 Analysts 7 Introduction 8 Antifungal Overview 10 Fungal Diseases 10 Risk Factors for Fungal Diseases 13 Antifungal Agents 14 Structure and Mechanism of Action 17 Treatment Alternatives 32 Indications and Side...
BioPortfolio Limited 10 Summary 13 Key metrics 14 CHAPTER 2 INTRODUCTION AND SCOPE 26 Coverage of the Stakeholder Insight Invasive Fungal Infections Survey 26 Methodology – points to note 28 CHAPTER 3 E EMIOLOGY AND PATIENT SEGMENTATION 30 Invasive fungal infections definition and classification 30 Etiology of invasive fungal infections 31 Aspergillosis 32 Blastomycosis 33 Candidiasis 33...
Vicuron Pharmaceuticals | About Vicuron | Company Overview | Who We Are Who We Are Vicuron Pharmaceuticals is an international biopharmaceutical company focused on discovering, developing, manufacturing and commercializing vital medicine for seriously ill patients.anidulafungin, a novel antifungal agent, and dalbavancin, a novel intravenous antibiotic for the treatment of...
Vicuron Pharmaceuticals | Products | Proprietary Products | Anidulafungin Anidulafungin Serious fungal infections affect patients with compromised immune systems and are often fatal despite current treatments.anidulafungin, a novel antifungal agent in a unique class, known as the echinocandins.
Vicuron Pharmaceuticals | Site Map Site Map About Vicuron Company Overview - - Who We Are - - Market Opportunity People of Vicuron - - Management Team - - Board of Directors Contact Products Pipeline Proprietary Products - - Anidulafungin - - Dalbavancin - - Other Pipeline Products Collaborations - - Oxazolidinones - - Deformylase Inhibitors - - VITACHEM Project Research Engine Drug Discovery Research Combined...
Database A A - investigational drugs, therapies and vaccines # - A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z From this page you may order documents with information covering investigational products.
Pharmaceutical Research and Manufacturers of America - Versicor Complete a new search Drug Name (Proprietary name/Generic name) Indications Addressed Click on indication to see all drugs for that indication Company Click a company to see all drugs for that company Development Status Notes anidulafungin none / anidulafungin Aspergillosis Candidiasis Versicor Fremont, CA Phase III - dalbavancin none / dalbavancin Skin and...
Pharmaceutical Research and Manufacturers of America - Candidiasis Complete a new search Drug Name (Proprietary name/Generic name) Indications Addressed Click on indication to see all drugs for that indication Company Click a company to see all drugs for that company Development Status Notes anidulafungin none / anidulafungin Aspergillosis Candidiasis Versicor Fremont, CA Phase III - P-113L none / none Candidiasis Mucositis...
Pharmaceutical Research and Manufacturers of America - Aspergillosis Complete a new search Drug Name (Proprietary name/Generic name) Indications Addressed Click on indication to see all drugs for that indication Company Click a company to see all drugs for that company Development Status Notes anidulafungin none / anidulafungin Aspergillosis Candidiasis Versicor Fremont, CA Phase III - ravuconazole none / ravuconazole...
Cancer.gov - Dictionary Cancer.gov Dictionary # A B C D E F G H I - J K L M N O P Q R S T U V W X Y Z A A33 monoclonal antibody -- A type of monoclonal antibody used in cancer detection or therapy
01-331 PhRMA NewMed InfDis3/8 2002 Infectious Diseases N E W M E D I C I N E S I N D E V E L O P M E N T F O R Survey P R E S E N T E D B Y A M E R I C A' S P H A R M A C E U T I C A L C O M P A N I E S A s the age- old war against infectious diseases enters a newN and frighteningN phase, pharmaceutical and biotechnology companies are rising to the heightened challenges
author: RL
duplicates:http://www.phrma.org/newmedicines/resources/2003-06-17.111.pdf http://www.phrma.org/newmedicines/resources/2003-05-12.108.pdf
01-331 PhRMA NewMed InfDis3/8 page 5
author: RL
duplicates:http://www.phrma.org/newmedicines/resources/2003-06-17.111.pdf http://www.phrma.org/newmedicines/resources/2003-05-12.108.pdf
48759231.pdf Investigator Div Source (Type) Title Apr- Jun- 2003 Apr- Jun- 2003 Period Awarded Awarded ABBOUD, FRANCOIS BRENNAN, THERESA FARACI, FRANK FARACI, FRANK HEISTAD, DONALD MARK, ALLYN MILLER, FRANCIS OREN, RON OREN, RON PULUKURTHY, SATYA ROSSEN, JAMES SIGMUND, CURT SIGMUND, CURT SNYDER, PETER WEISS, ROBERT HAYNES, WILLIAM VAN ROLLINS, MIKE DILLON, JOSEPH O'DORISIO, THOMAS CAD CAD CAD CAD...
author: Oracle Reports
48759231.pdf page 3
author: Oracle Reports
Contents Vol. 4, No. 3, 2003 3, 2003 Contents Original Research Effects of Levocarnitine on Mitochondrial Antioxidant 141- 147 Articles Systems and Oxidative Stress in Aged Rats S Kumaran, B Deepak, B Naveen, C Panneerselvam Hydroxyethyl Starch (HES) , a New HES Specification: 149- 157 Pharmacokinetics and Safety after Multiple Infusions of 10% Solution in Healthy Volunteers J Waitzinger, F Bepperling, G Pabst,...
author: Adis International Limited
subject: Drugs in R and D
The Next Generation Antifungals: Triazoles vs. Peptides Table of Contents Executive Summary 5 Methodology 7 Information Sources 7 Analysts 7 Introduction 8 New members of the azole antifungals; The triazols 13 Echinocandins/Cyclic Peptide Antifungals 14 The Triazols 16 Voriconazole Vfend 16 Ravuconazole 22 Posaconazole 25 TAK-456 and TAK-457 30 ZD0870 31 UR-9625, UR-9746, UR-9751 and UR-9825 31 T-8581 32 CS-758 33 SS-750 33 Genaconazole...
http://www.adis.com/files/newsletters/AIT/AICOV52.pdf 12 Apr 2003 NoAnidulafungin vs fluconazole in oesophageal candidiasis 7 Anthrax toxin antagonist protects against anthrax 7...
http://www.adis.com/files/newsletters/INP/ICOV1380.pdf 20 ENDOCRINOLOGY Antiandrogens (nonsteroidal): associated gynaecomastia 21 BMP- 9: role in glucose homeostasis 11 Filgrastim: no added benefit for infected diabetic foot ulcers 15 GASTROENTEROLOGY Esomeprazole, lansoprazole similar efficacy in GERD 18 Lansoprazole, esomeprazole similar efficacy in GERD 18 PPIs: GERD- related spending higher 4 IMMUNOTHERAPY Basiliximab: economic...
Microsoft Word - Document2 (Nuovo Mercato: BIO) today announced the completion of their merger, creating a transatlantic company focused on the discovery, development, manufacture and commercialization of novel antibiotic and antifungal agents for tough- to- treat infections The new company's stock will continue to trade under the ticker symbol VERS on the Nasdaq National Market in the United States and will...
author: mmonticelli
